Newsmeme!
Discover News you didn't know existed
The reduction in customs duty of life saving drugs in the Union Budget 2009-10 has not enthused the members of the Indian biotech industry. They are of the view that the move can mainly help the multinational drug companies.
Children sometimes complain about aches in their joints. These aches could result from a variety of causes. But, if a child’s joints are swollen for six weeks in a row or longer, he or she may have juvenile arthritis (JA).
THURSDAY, July 9 (HealthDay News) -- An arthritis therapy appears to increase the risk of tuberculosis in certain patients, French researchers have found.
It was another largely disappointing performance by the nation's retailers in June, but the fact that their reports didn't sink the market was encouraging. Weather was one factor last month; the Northeast was particularly rainy during the month, which likely kept some shoppers at home.
But researchers still don't know why a certain therapy appears to reactivate latent TB
A 36-year-old woman with rheumatoid arthritis who was receiving systemic immunotherapy died from disseminated histoplasmosis while participating in a gene-therapy trial of a tumor necrosis factor {alpha} antagonist delivered through an adeno-associated viral vector delivery system and administered by intraarticular injection.
MONTREAL, QUEBEC, CANADA--(Marketwire - July 8, 2009) - Allostera Pharma Inc. today announced it has secured a Series A financing of $17 million (Canadian dollars). Four venture funds participated: iNovia Capital, Genesys Capital, BDC Venture Capital with GO Capital, and Fonds Bio-Innovation s.e.c. The proceeds of the financing will be used for the development of Allosteramers(TM), a new class ...
When unanticipated health problems arise the medical bills can pile up quickly, adding stress to an already difficult situation.
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA).
MorphoSys AG and the University of Melbourne announced an agreement to cooperate on investigating new therapeutic applications for MorphoSys's MOR103 programme.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |